Vijay Ramsawami

88PUBLICATIONS
424CO-AUTHORS
Medical infection agents (incl. prions)Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsGene and molecular therapyInfant and child health
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (88)

|Aug 05, 2026
Pediatric ependymoma in the molecular era: real-world experience with diagnostic correlation and long-term clinical outcomes.

|Jul 25, 2026
Reply to: Comment on: Group 4 Medulloblastomas of Early Childhood Treated With High-Dose Chemotherapy- and Craniospinal Irradiation-Sparing Approach-Finding the Right Balance Between Survival and Survivorship.

|Jul 09, 2026
Paediatric therapeutic development workshop on medulloblastoma.

|Jul 07, 2026
From developmental origins to relapse: molecular and therapeutic insights in medulloblastoma.

|Mar 26, 2026
Androgen activity in the male embryonic hindbrain drives lethal PFA ependymoma.

Jiao Zhang, Winnie Ong, Alexandra Rasnitsyn

|Mar 02, 2026
Publisher Correction: An OTX2-PAX3 signaling axis regulates Group 3 medulloblastoma cell fate.

Jamie Zagozewski, Ghazaleh M Shahriary, Ludivine Coudière Morrison

Pageof 15

Frequent Collaborators

24 joint publications

Eric Bouffet

14 joint publications

Michael D Taylor

12 joint publications

Uri Tabori

9 joint publications

Stefan M Pfister